美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Astellas Pharma, Inc.

12.85

0.0000

成交量：6

成交额：84.90

市值：239.24亿

市盈率：172.83

高：12.85

开：12.85

低：12.85

收：12.85

52周最高：17.85

52周最低：9.54

股本：18.62亿

流通股本：17.31亿

量比：0.00

换手率：NaN%

股息：0.48

股息率：3.70%

每股收益(TTM):0.0744

每股收益(LYR):0.0628

净资产收益率：17.44%

总资产收益率：7.95%

市净率：2.14

市盈率(LYR):204.48

数据加载中...

总览公司新闻公告

辉瑞与安斯泰来Padcev联合Keytruda膀胱癌适应症获FDA优先审评

安斯泰来制药：FDA根据《处方药使用者费用法案》设定2026年8月17日为关键审批日期

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALPMF/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":12.85,"timestamp":1784902723627,"preClose":12.85,"halted":0,"volume":6,"delay":15,"changeRate":0,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"休市中","change":0,"latestTime":"07-24 10:18:43 EDT 延时","open":12.85,"high":12.85,"low":12.85,"amount":84.9,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1533355200000,"exchange":"PINK LIMITED","adjPreClose":12.85,"volumeRatio":0.003764115881544553},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","floatShares":1731101601,"roa":"7.95%","roe":"17.44%","lyrEps":0.062841,"volumeRatio":0.003764115881544553,"shares":1861787075,"dividePrice":0.476034,"high":12.85,"amplitude":0,"preClose":12.85,"low":12.85,"week52Low":9.54,"pbRate":"2.14","psRate":"1.83","week52High":17.85,"institutionHeld":0,"latestPrice":12.85,"eps":0.074352,"divideRate":0.037045,"volume":6,"delay":15,"ttmEps":0.074352,"open":12.85,"prevYearClose":13.17,"prevWeekClose":13.675,"prevMonthClose":14.5,"prevQuarterClose":14.5,"fiveDayClose":13.675,"twentyDayClose":12.85,"sixtyDayClose":14.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-25","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null},{"date":"2023-09-28","symbol":"ALPMF","amount":35,"announcedDate":"2023-07-19","type":"dividend","market":"US","newRecordDate":"2023-09-30","defaultRemindTime":1695907800000,"name":"Astellas Pharma, Inc.","recordDate":"2023-12-01","payableDate":"2023-09-30","currency":"JPY","dateTimestamp":1695873600000,"payDate":"2023-12-01"},{"market":"US","date":"2023-08-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690862400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMF\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-27","recordDate":"2019-03-31","paymentDate":"2019-06-18","value":19,"currency":"JPY"},{"executeDate":"2019-09-27","recordDate":"2019-09-30","paymentDate":"2019-12-03","value":20,"currency":"JPY"},{"executeDate":"2020-03-30","recordDate":"2020-03-31","paymentDate":"2020-06-19","value":20,"currency":"JPY"},{"executeDate":"2020-09-29","recordDate":"2020-09-30","paymentDate":"2020-12-01","value":21,"currency":"JPY"},{"executeDate":"2021-03-30","recordDate":"2021-03-31","paymentDate":"2021-06-01","value":21,"currency":"JPY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMF\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628747934","title":"辉瑞与安斯泰来Padcev联合Keytruda膀胱癌适应症获FDA优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2628747934","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628747934?lang=zh_cn&edition=fundamental","pubTime":"2026-04-20 19:29","pubTimestamp":1776684597,"startTime":"0","endTime":"0","summary":"金吾财讯 | 辉瑞 与安斯泰来周一宣布，双方合作开发的抗体药物偶联物 Padcev 联合默沙东抗 PD-1 疗法 Keytruda 用于治疗膀胱癌的上市申请，已获得美国 FDA 优先审评资格。此次申请旨在将该联合疗法的适用人群扩展至所有肌层浸润性膀胱癌患者，不再受限于是否耐受顺铂的化疗。早在去年 11 月，FDA 已批准该组合疗法用于术前及术后，治疗无法接受顺铂化疗的肌层浸润性膀胱癌患者。FDA 将 2026 年 8 月 17 日定为此次补充生物制品许可申请的目标审批日期。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299435","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","LU0106261372.USD","LU1989772840.SGD","IE00B1BXHZ80.USD","LU1037948897.HKD","LU1941712264.USD","SG9999014559.SGD","BK4533","LU0098860793.USD","SG9999002224.SGD","LU1934455863.HKD","LU2461242641.AUD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0306806265.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1069347547.HKD","ALPMF","LU1291159041.SGD","IE00B2B36J28.USD","LU0265550359.USD","LU1116320901.HKD","SG9999014542.SGD","LU0477156953.USD","BK4585","LU2023250843.SGD","IE000M9KFDE8.USD","LU1585245621.USD","LU1023059063.AUD","LU1061106388.HKD","LU0203345920.USD","LU1934455277.USD","BK4581","LU1093756168.USD","LU0208291251.USD","LU0965508806.USD","LU0203347892.USD","LU2106854487.HKD","LU0965509283.SGD","LU0225771236.USD","SG9999014567.USD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","SG9999014575.USD","LU0985320562.USD","LU0225284248.USD","LU0868494708.USD","LU2023250504.SGD","BK4007","LU2360032135.SGD","LU0861579265.USD","LU0211331839.USD","LU0320765489.SGD","LU0306807586.USD","LU1989772923.USD","IE00BN8TJ469.HKD","LU1057294990.SGD","IE0009355771.USD","LU2112291526.USD","LU0432979614.USD","LU2125154778.USD","LU1941712348.USD","LU0006306889.USD","LU0265550946.USD","LU0868494617.USD","LU1699723380.USD","PFE","SG9999015358.SGD","BK4559","LU0170899867.USD","LU2361044949.HKD","LU1116320737.USD","IE00B4R5TH58.HKD","BK4599","LU0985481810.HKD","LU2361044865.SGD","SG9999001176.USD","LU0942090050.USD","IE0002141913.USD","IE00BBT3K403.USD","LU1201861249.SGD","LU0321505868.SGD","IE00BSNM7G36.USD","LU0320765646.SGD","LU0965509010.AUD","LU0058720904.USD","LU1037948541.HKD","LU1894683348.USD","MRK","SG9999015341.SGD","LU0648001328.SGD","LU0859254822.USD","BK4592","LU2468319806.SGD","LU1093756325.SGD","BK4588","LU1883839398.USD","LU2357627491.SGD","SG9999002232.USD","LU0238689110.USD","LU1974910355.USD","LU1989771016.USD","LU0965509101.SGD","LU2361045086.USD","LU2324357040.USD","LU0266013472.USD","SG9999001440.SGD","SG9999001176.SGD","LU0289739699.SGD","LU2089984988.USD","LU1430594728.SGD","BK4534","LU2125154935.USD","BK4568","IE00B19Z3581.USD","LU0321505439.SGD","BK4550","LU1035773651.USD","LU1066053197.SGD","LU1917777945.USD","LU0122379950.USD","LU1066051498.USD","LU0070302665.USD","LU1983299246.USD","LU1934455194.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU0234572021.USD","LU1162221912.USD","LU0130102774.USD","SG9999013999.USD","LU0130517989.USD","LU0980610538.SGD","SGXZ57979304.SGD","IE0002270589.USD","LU1066051225.USD","LU1571399168.USD","LU0456855351.SGD","LU1066051811.HKD","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159770601","title":"安斯泰来制药：FDA根据《处方药使用者费用法案》设定2026年8月17日为关键审批日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159770601","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159770601?lang=zh_cn&edition=fundamental","pubTime":"2026-04-20 18:48","pubTimestamp":1776682090,"startTime":"0","endTime":"0","summary":"根据《处方药使用者费用法案》框架，美国食品药品监督管理局已为安斯泰来制药的核心新药申请划定重要时间节点——2026年8月17日被正式确立为监管审评的目标行动日期。这一关键时间点的设定，标志着该创新疗法的审评进程进入倒计时阶段，为市场预期提供了明确的时间坐标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0058720904.USD","BK4550","BK4599","LU0289739699.SGD","SG9999002232.USD","ALPMY","LU1057294990.SGD","LU0321505439.SGD","BK4568","IE00B19Z3581.USD","BK4007","BK4588","ALPMF","LU0170899867.USD","LU1066053197.SGD","LU0122379950.USD","LU0225284248.USD","LU0456855351.SGD","LU1894683348.USD","IE0002270589.USD","LU0306807586.USD","SG9999001176.USD","LU0985481810.HKD","SG9999011175.SGD","BK4585","BK4534","SG9999003800.SGD","BK4592","LU1883839398.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4581","LU0321505868.SGD","SG9999002224.SGD","SG9999001176.SGD","SGXZ57979304.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225771236.USD","LU0868494617.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0306806265.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}